TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Dne Pharma AS
Closing information (x1000 EUR)
Closing information | 2019/12 | 2018/12 | 2017/12 |
Turnover | 2,856 | 4,444 | 5,364 |
Financial expenses | 120 | 232 | 8 |
Earnings before taxes | -461 | 1,503 | 1,161 |
Total assets | 6,302 | 10,729 | 4,034 |
Current assets | 2,582 | 7,875 | 3,165 |
Current liabilities | 1,465 | 4,974 | 2,585 |
Equity capital | 4,452 | 4,733 | 1,429 |
- share capital | 14 | 14 | 14 |
Employees (average) | 7 | ||
Shareholders | 0 | 0 | 0 |
Financial ratios
Fiscal year | 2019/12 | 2018/12 | 2017/12 |
Solvency | 70.6% | 44.1% | 35.4% |
Turnover per employee | 766 | ||
Profit as a percentage of turnover | -16.1% | 33.8% | 21.6% |
Return on assets (ROA) | -5.4% | 16.2% | 29.0% |
Current ratio | 176.2% | 158.3% | 122.4% |
Return on equity (ROE) | -10.4% | 31.8% | 81.2% |
Change turnover | -1,663 | -819 | -3,730 |
Change turnover % | -37% | -16% | -41% |
Chg. No. of employees | 4 | ||
Chg. No. of employees % | 133% |
Total value of public sale
Fiscal year | 2019/12 | 2018/12 | 2017/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.